Literature DB >> 19234464

Universal epitopes of influenza virus hemagglutinins?

Taia T Wang, Peter Palese.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19234464     DOI： 10.1038/nsmb.1574

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN： 1545-9985            Impact factor:   15.369


× No keyword cloud information.
  13 in total

1.  An antibody that prevents the hemagglutinin low pH fusogenic transition.

Authors:  C Barbey-Martin; B Gigant; T Bizebard; L J Calder; S A Wharton; J J Skehel; M Knossow
Journal:  Virology       Date:  2002-03-01       Impact factor: 3.616

2.  Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120.

Authors:  Chih-chin Huang; Miro Venturi; Shahzad Majeed; Michael J Moore; Sanjay Phogat; Mei-Yun Zhang; Dimiter S Dimitrov; Wayne A Hendrickson; James Robinson; Joseph Sodroski; Richard Wyatt; Hyeryun Choe; Michael Farzan; Peter D Kwong
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

3.  V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen.

Authors:  C H Chan; K G Hadlock; S K Foung; S Levy
Journal:  Blood       Date:  2001-02-15       Impact factor: 22.113

4.  Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction.

Authors:  H P Brezinschek; R I Brezinschek; P E Lipsky
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422

5.  VH1-69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.

Authors:  W Pos; B M Luken; J A Kremer Hovinga; E A M Turenhout; F Scheiflinger; J-F Dong; R Fijnheer; J Voorberg
Journal:  J Thromb Haemost       Date:  2009-03       Impact factor: 5.824

6.  Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies.

Authors:  Arun K Kashyap; John Steel; Ahmet F Oner; Michael A Dillon; Ryann E Swale; Katherine M Wall; Kimberly J Perry; Aleksandr Faynboym; Mahmut Ilhan; Michael Horowitz; Lawrence Horowitz; Peter Palese; Ramesh R Bhatt; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-14       Impact factor: 11.205

7.  Molecular ontogeny of the human antibody repertoire to the Haemophilus influenzae type B polysaccharide: expression of canonical variable regions and their variants in vaccinated infants.

Authors:  Alexander H Lucas; Gary R McLean; Donald C Reason; Adam P O'Connor; Mistique C Felton; Karen D Moulton
Journal:  Clin Immunol       Date:  2003-08       Impact factor: 3.969

8.  Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia.

Authors:  Mario Perotti; Nadia Ghidoli; Raffaele Altara; Roberta A Diotti; Nicola Clementi; Donata De Marco; Monica Sassi; Massimo Clementi; Roberto Burioni; Nicasio Mancini
Journal:  Autoimmun Rev       Date:  2008-04-10       Impact factor: 9.754

9.  Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses.

Authors:  Jianhua Sui; William C Hwang; Sandra Perez; Ge Wei; Daniel Aird; Li-mei Chen; Eugenio Santelli; Boguslaw Stec; Greg Cadwell; Maryam Ali; Hongquan Wan; Akikazu Murakami; Anuradha Yammanuru; Thomas Han; Nancy J Cox; Laurie A Bankston; Ruben O Donis; Robert C Liddington; Wayne A Marasco
Journal:  Nat Struct Mol Biol       Date:  2009-02-22       Impact factor: 15.369

10.  Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.

Authors:  Mark Throsby; Edward van den Brink; Mandy Jongeneelen; Leo L M Poon; Philippe Alard; Lisette Cornelissen; Arjen Bakker; Freek Cox; Els van Deventer; Yi Guan; Jindrich Cinatl; Jan ter Meulen; Ignace Lasters; Rita Carsetti; Malik Peiris; John de Kruif; Jaap Goudsmit
Journal:  PLoS One       Date:  2008-12-16       Impact factor: 3.240
View more
  24 in total

1.  Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation.

Authors:  Jacob Glanville; Tracy C Kuo; H-Christian von Büdingen; Lin Guey; Jan Berka; Purnima D Sundar; Gabriella Huerta; Gautam R Mehta; Jorge R Oksenberg; Stephen L Hauser; David R Cox; Arvind Rajpal; Jaume Pons
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

2.  Multi-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactone.

Authors:  Peter Pushko; Irina Tretyakova; Rachmat Hidajat; Xiangjie Sun; Jessica A Belser; Terrence M Tumpey
Journal:  Vaccine       Date:  2018-06-07       Impact factor: 3.641

3.  Highly conserved protective epitopes on influenza B viruses.

Authors:  Cyrille Dreyfus; Nick S Laursen; Ted Kwaks; David Zuijdgeest; Reza Khayat; Damian C Ekiert; Jeong Hyun Lee; Zoltan Metlagel; Miriam V Bujny; Mandy Jongeneelen; Remko van der Vlugt; Mohammed Lamrani; Hans J W M Korse; Eric Geelen; Özcan Sahin; Martijn Sieuwerts; Just P J Brakenhoff; Ronald Vogels; Olive T W Li; Leo L M Poon; Malik Peiris; Wouter Koudstaal; Andrew B Ward; Ian A Wilson; Jaap Goudsmit; Robert H E Friesen
Journal:  Science       Date:  2012-08-09       Impact factor: 47.728

4.  Bispecific antibody generated with sortase and click chemistry has broad antiinfluenza virus activity.

Authors:  Koen Wagner; Mark J Kwakkenbos; Yvonne B Claassen; Kelly Maijoor; Martino Böhne; Koenraad F van der Sluijs; Martin D Witte; Diana J van Zoelen; Lisette A Cornelissen; Tim Beaumont; Arjen Q Bakker; Hidde L Ploegh; Hergen Spits
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

5.  A highly conserved neutralizing epitope on group 2 influenza A viruses.

Authors:  Damian C Ekiert; Robert H E Friesen; Gira Bhabha; Ted Kwaks; Mandy Jongeneelen; Wenli Yu; Carla Ophorst; Freek Cox; Hans J W M Korse; Boerries Brandenburg; Ronald Vogels; Just P J Brakenhoff; Ronald Kompier; Martin H Koldijk; Lisette A H M Cornelissen; Leo L M Poon; Malik Peiris; Wouter Koudstaal; Ian A Wilson; Jaap Goudsmit
Journal:  Science       Date:  2011-07-07       Impact factor: 47.728

6.  Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses.

Authors:  Darrell R Kapczynski; Terrence M Tumpey; Rachmat Hidajat; Aniko Zsak; Klaudia Chrzastek; Irina Tretyakova; Peter Pushko
Journal:  Vaccine       Date:  2016-02-08       Impact factor: 3.641

Review 7.  Passive immune neutralization strategies for prevention and control of influenza A infections.

Authors:  Jianqiang Ye; Hongxia Shao; Daniel R Perez
Journal:  Immunotherapy       Date:  2012-02       Impact factor: 4.196

8.  Attacking the flu: neutralizing antibodies may lead to 'universal' vaccine.

Authors:  Grace L Chen; Kanta Subbarao
Journal:  Nat Med       Date:  2009-11       Impact factor: 53.440

9.  Convergent antibody signatures in human dengue.

Authors:  Poornima Parameswaran; Yi Liu; Krishna M Roskin; Katherine K L Jackson; Vaishali P Dixit; Ji-Yeun Lee; Karen L Artiles; Simona Zompi; Maria José Vargas; Birgitte B Simen; Bozena Hanczaruk; Kim R McGowan; Muhammad A Tariq; Nader Pourmand; Daphne Koller; Angel Balmaseda; Scott D Boyd; Eva Harris; Andrew Z Fire
Journal:  Cell Host Microbe       Date:  2013-06-12       Impact factor: 21.023

10.  Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin.

Authors:  Jean-Michel Garcia; Stephanie Pepin; Nadège Lagarde; Edward S K Ma; Frederick R Vogel; Kwok H Chan; Susan S S Chiu; J S M Peiris
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.